Next Article in Journal
Three-Dimensional Modeling of Spun-Bonded Nonwoven Meso-Structures
Next Article in Special Issue
Chitin and Chitosan as Polymers of the Future—Obtaining, Modification, Life Cycle Assessment and Main Directions of Application
Previous Article in Journal
Characterization and Gel Properties of Low-Molecular-Weight Carrageenans Prepared by Photocatalytic Degradation
Previous Article in Special Issue
Preparation, Characterization and Anti-Complementary Activity of Three Novel Polysaccharides from Cordyceps militaris
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chitosan/Gelatin Scaffolds Loaded with Jatropha mollissima Extract as Potential Skin Tissue Engineering Materials

by
Matheus Ferreira de Souza
1,
Henrique Nunes da Silva
1,
José Filipe Bacalhau Rodrigues
1,
Maria Dennise Medeiros Macêdo
1,
Wladymyr Jefferson Bacalhau de Sousa
2,
Rossemberg Cardoso Barbosa
2 and
Marcus Vinícius Lia Fook
2,*
1
Postgraduate Program in Materials Science and Engineering, Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, PB, Brazil
2
Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, PB, Brazil
*
Author to whom correspondence should be addressed.
Polymers 2023, 15(3), 603; https://doi.org/10.3390/polym15030603
Submission received: 31 December 2022 / Revised: 12 January 2023 / Accepted: 17 January 2023 / Published: 24 January 2023

Abstract

:
This work aimed to develop chitosan/gelatin scaffolds loaded with ethanolic extract of Jatropha mollissima (EEJM) to evaluate the influence of its content on the properties of these structures. The scaffolds were prepared by freeze-drying, with different EEJM contents (0–10% (w/w)) and crosslinked with genipin (0.5% (w/w)). The EEJM were characterized through High Performance Liquid Chromatography coupled to a Diode Array Detector (HPLC-DAD), and the determination of three secondary metabolites contents was accomplished. The physical, chemical and biological properties of the scaffolds were investigated. From the HPLC-DAD, six main substances were evidenced, and from the quantification of the total concentration, the condensed tannins were the highest (431.68 ± 33.43 mg·g−1). Spectroscopy showed good mixing between the scaffolds’ components. Adding and increasing the EEJM content did not significantly influence the properties of swelling and porosity, but did affect the biodegradation and average pore size. The enzymatic biodegradation test showed a maximum weight loss of 42.89 within 28 days and reinforced the efficiency of genipin in crosslinking chitosan-based materials. The addition of the extract promoted the average pore sizes at a range of 138.44–227.67 µm, which is compatible with those reported for skin regeneration. All of the scaffolds proved to be biocompatible for L929 cells, supporting their potential application as skin tissue engineering materials.

1. Introduction

Tissue engineering aims to develop and use biomaterials, such as scaffolds, to support adequate tissue regeneration and repair. These are structures with pores of varying sizes and shapes, interconnected or not. Such characteristics are defined depending on the cell type of the tissue or organ to which a scaffold will be applied [1,2,3].
Among the biomaterials investigated for the development of scaffolds for the treatment of skin lesions, natural polymers or biopolymers (hyaluronic acid, collagen, chitin, chitosan, among others) have played an adequate role due to their biocompatibility, biodegradability, and similarity with the macromolecules recognized by the human body, making them excellent mimics of extracellular matrix (ECM) systems [4]. The combination of polysaccharide and protein, such as chitosan and gelatin, respectively, proved to be a functional strategy to mimic the native ECM, and are, therefore, an excellent alternative for the development of scaffolds for tissue engineering [5,6,7].
Chitosan is an abundant polysaccharide with properties that include antibacterial action, biodegradability, and cytocompatibility [8,9,10]. However, the low mechanical strength of pure chitosan-based biomaterials limits their application. In this sense, to optimize their mechanical properties, the use of crosslinking agents, such as genipin, is a viable alternative [11,12,13]. Moreover, according to Si et al. [14], the effect of pure chitosan in promoting cell proliferation is limited due to the lack of clues to induce cell migration and differentiation on the surface of scaffolds. In this sense, the development of chitosan-based scaffolds in combination with other biopolymers, such as gelatin, is reported.
Blending chitosan with gelatin is effective as the protein contains an Arg–Gly–Asp (RGD)-like sequence that promotes cell adhesion and migration and forms a polyelectrolyte complex with such polysaccharide [15,16,17,18]. Xu et al. [19] developed scaffolds based on chitosan, gelatin and decellularized extracellular matrix by freeze-drying with high biocompatibility, as well as good antibacterial activity and the appropriate mechanical properties for skin tissue engineering. Zhang et al. [20] built sandwich-like scaffolds of chitosan, gelatin and polycaprolactone by electrospinning and lyophilization; the resulting product had good biocompatibility and was capable of accelerating blood clotting for guided periodontal tissue regeneration. Casimiro et al. [21] conducted in vitro and in vivo studies for scaffolds based on chitosan, gelatin and polyvinyl alcohol obtained by freeze-drying and ionizing radiation techniques, the results obtained, with good vascularization and a faster healing process, set these materials as a promising potential as a new alternative for skin wound healing. Furthermore, in order to develop new biomaterials and investigate the potentiality and properties of new substances for tissue engineering, studies on the incorporation of natural derivatives in chitosan/gelatin structures, such as essential oils and plant extracts, have been carried out [22,23,24].
The latex and extracts of Jatropha molissima (Pohl) Bail, a plant of the Euphorbiaceae family popularly known in Brazil as “pinhão-bravo”, are widely used in folk medicine, mainly for promoting anti-inflammatory, antibacterial and antioxidant action resulting from secondary metabolites [25]. Dias et al. [26] evaluated the antioxidant and cytogenotoxic potential of hexane (HE), ethyl acetate (EA) and methanol (ME) extracts from “pinhão-bravo” leaves and concluded that the ME extract is promising as an antioxidant as it showed no cytogenotoxic effect. Although the HE and EA extracts did not show cytogenotoxic activity, they inhibited cell division in Allium cepa cells at all of the evaluated concentrations, which may be promising for antitumor activity studies. Queiroz Neto et al. [27] investigated the chemical composition and pharmacological activities of J. molissima derivatives. It was observed that they have good antioxidant activity and that, even at low concentrations, both its latex and extracts inhibit the growth of gram (+) and gram (-) bacteria, evidencing the antibacterial property of the compounds, attributed to the presence of secondary metabolites.
Although the properties of J. molissima derivatives have already been studied, their application in the development of tissue engineering materials has not yet been reported, as well as the effects of their combination with chitosan and gelatin for the potential treatment of wounds. In this sense, this work aims to develop scaffolds based on chitosan, gelatin and ethanolic extract of Jatropha mollissima (EEJM). The EEJM and scaffolds’ properties are studied.

2. Materials and Methods

2.1. Materials

Chitosan of high molecular weight and degree of deacetylation of ~80% was provided by the Northeastern Biomaterials Evaluation and Development Laboratory–CERTBIO (Campina Grande, PB, Brazil). Gelatin from porcine skin, phosphate-buffered saline (PBS), lysozyme and genipin were purchased from Sigma-Aldrich®, Merck Group (Darmstadt, Germany). Acetic acid and absolute ethyl alcohol were purchased from Neon® (Suzano, –SP, Brazil). The latex of Jatropha mollissima (Genetic Heritage No. AD5B98B) was collected at Sítio Valente, located in the city of Boa Vista–PB, Brazil (Lat 7° 20’ 18.29” S Long 36°14’ 17.11” W).

2.2. Methods

2.2.1. Development of the Ethanolic Extract of Jatropha mollissima

The procedures for the identification, collection and extraction of the plant sample of J. molíssima were carried out according to the methodology of Ribeiro et al. [28]. Initially, the botanical identification was performed at the Manuel Arruda Câmara Herbarium (ACAM) of the State University of Paraíba–UEPB. After selecting the specimen, based on their harmful action on the plant stem, the latex was collected in sterile tubes wrapped in aluminium foil. Then, the material was kept under refrigeration (approximately 5 °C) and protected from light until the next step.
The ethanolic extract of J. mollissima was developed based on the methodology described by Dantas et al. [29]. First, the raw latex was mixed with absolute ethyl alcohol in a 1:1 ratio, conditioned at room temperature and protected from light for three days, using 1 (one) liter of latex to evaluate the process yield. Then, the mixture was subjected to vacuum filtration and rotary evaporation at 50 °C and 30 rpm. Finally, the liquid was frozen in an ultra-freezer (−80 °C) for 24 h and subjected to lyophilization for 72 h in a LIOTOP model L108 lyophilizer (São Carlos, São Paulo, Brazil). After the end of the process, the EEJM powder was stored under ambient conditions.

2.2.2. Scaffolds Preparation

The scaffolds were prepared by solution mixing. Initially, solutions of 2% w/v of chitosan (1% of acetic acid) and 2% of gelatin were developed in a Nova Ética model M 110-VER-4K3 mechanical shaker (Vargem Grande do Sul, São Paulo, Brazil) for one hour, the last one at 40 °C. Then, the solutions were mixed in a 70/30 ratio of chitosan/gelatin for another hour. Afterwards, the EEJM were added in the appropriate proportion (0, 1, 2.5, 5, 7.5 ou 10%), maintaining mechanical agitation for one hour and, finally, 0.5 % w/w genipin (30 min of mixing) at 40 °C. These steps were carried out using constant agitation (400 rpm). The final solutions were poured into 6-well plates, with 3 mL per well. Then, the plates were submitted to the ultra-freezer (−80 °C) for 24 h and, finally, freeze-dried for 24 h to obtain the scaffolds. The samples were neutralized in an atmosphere of ammonium hydroxide (1M), followed by washing several times with distilled water, freezing and lyophilization for 12 h. The biopolymer ratio and genipin content were defined based on previous exploratory tests. Table 1 presents the studied EEJM contents, as well as the sample coding.

2.3. Characterization

2.3.1. High Performance Liquid Chromatography coupled to Diode Array Detector

The High Performance Liquid Chromatography coupled to the Diode Array Detector (HPLC-DAD) technique was applied to obtain the fingerprint and identify the main groups of secondary metabolites present in the EEJM. Chromatographic analyzes were performed on a Flexar series liquid chromatography system (Perkin Elmer, Waltham, USA) equipped with an automatic injector, oven, binary pump and diode array detector (DAD) (Flexar PDA Plus Detector). Ultrapure water, acetonitrile and methanol were used as solvents.
A 1% (v/v) acetic acid aqueous solution (A) and acetonitrile (B) were used as eluents. Analyzes were conducted on a C18 column (250 × 4.6 mm, 5 µm particle size) employing the gradient mode under the following conditions: 5% B, 0–1 min; 5–10% B, 1–5 min; 10–20% B, 5–14 min; 20–21% B, 14–24 min; 21–95% B, 24–29 min. In the equilibration and washing steps, 5% B for 5 min and 95% B for 10 min were used, respectively. The eluent flow was maintained at 0.480 mL.min−1, and 20 µL of the sample was injected. The oven temperature was 30 ± 1 °C. The wavelength of 280 nm was monitored. The total analysis time was 29 min.
The EEJM samples were prepared at a concentration of 2.5 mg.mL−1 in a 95/5 (v/v) water/acetonitrile solution, with the same initial mobile phase ratio. This proportion was chosen because samples prepared in the same initial proportion of mobile phase present a better separation of substances [30]. The samples and solvents were filtered through 0.45 µm membranes. Before each analysis, the HPLC-DAD system was equilibrated, and the baseline was monitored until stable. All of the solvents used were degassed by ultrasound.

2.3.2. Determination of Phenolic, Flavonoid and Condensed Tannins Contents

The determination of total polyphenols in the ethanolic extract of J. mollissima was performed using the Folin-Ciocalteu method [31]. Initially, an aqueous mother solution of gallic acid (100 µg·mL−1) and its dilutions (1–40 µg·mL−1) were prepared. Then, 250 µL of each curve point were mixed with 2.5 mL of 2 M Folin-Ciocalteu reagent and 2 mL of 20% (w/v) sodium carbonate solution. After 30 min, readings were taken in a Spectrophotometer model UV-1800 (Shimadzu, Kyoto) at room temperature (25 °C) in a 300–1100 nm scan using a quartz cuvette with an optical path of 1 cm and 4 polished sides model Q-204. The preparation of the EEJM sample was carried out similarly to that of the gallic acid mother solution. The absorbance values of the 770 nm wavelength were recorded. The concentration of total polyphenols was expressed as a function of the equivalent concentration of gallic acid (mg GAE/g) in the dry extract. The quantification of the total flavonoids in the ethanolic extract of J. mollissima was performed according to the colorimetric method of aluminium chloride (AlCl3) [32]. There are three steps for this: preparation of the calibration curve, sample preparation, and data collection. For the calibration curve, quercetin methanolic solutions (mother solution) at 30 µg·mL−1, followed by their respective dilutions (3–30 µg·mL−1), were prepared. Then, 1.5 mL of each solution was individually mixed with 1.5 mL of 2% (w/v) aluminium chloride (AlCl3) solution. After 30 min, the absorbance of the solutions was recorded at a wavelength of 445 nm by means of a Spectrophotometer model UV-1800 (Shimadzu, Kyoto) at room temperature (25 °C) in a scan of 300–1100 nm using a cuvette quartz crystal with an optical path of 1 cm with 4 polished faces model Q-204. The sample preparation was carried out similarly to the quercetin stock solution. The concentration of total flavonoids was expressed as a function of the equivalent concentration of quercetin (mg QE/g) in the dry extract. The Vanillin-Hydrochloric Acid (HCl) method, reported by Palacios et al. [33], was used to determine the total concentration of condensed tannins. Initially, a methanolic stock solution of catechin (550 µg·mL−1) and its respective dilutions (10–500 µg·mL−1) were prepared. Then, 3 mL of a 4% (w/v) vanillin solution, 500 µL of the calibration curve point solutions and 1.5 mL of a 0.75 M HCl solution were transferred to test tubes and immersed in water at 22 °C for 20 min. The readings were performed in a Spectrophotometer model UV-1800 (Shimadzu, Kyoto) at room temperature (25 °C) in a scan of 300–1100 nm and using a quartz cuvette with an optical path of 1 cm with the 4 polished faces model Q -204. Sample preparation was carried out similarly to that of the catechin stock solution. The absorbance values of the 500 nm wavelength were recorded. The concentration of total condensed tannins was expressed as a function of the equivalent concentration of catechin (mg CE/g) in the dry extract. All of the measurements were performed in triplicate (n = 3).

2.3.3. Fourier Transform Infrared Spectroscopy

The precursor materials and scaffolds were submitted to Fourier Transform Infrared Spectroscopy (FTIR) using Perkin Elmer’s Spectrum 400 equipment (Waltham, MA, USA). The FTIR technique was performed to identify the characteristic bands and the chemical groups present in the samples. The wavelength range was between 4000 and 650 cm−1 at the scan speed of 32 scan/min with 16 cm−1 resolution.

2.3.4. Swelling Degree

The swelling degree (SD) of the scaffolds was evaluated in a PBS solution (pH = 7.4) in triplicate (n = 3). For the analysis, the samples (approximately 1 cm2) previously dried (60 °C) for 24 h were weighed, and then kept in a PBS solution at 37 °C for 24 h. When the determined time was reached, the samples were removed from the solution, slightly dried on a paper towel, and weighed again. The swelling degree was determined using Equation (1):
S D   % = W W 0 W 0 × 100 ,
where W0 is the initial sample weight, and W is the final sample weight.

2.3.5. Enzymatic Biodegradation

In vitro enzymatic biodegradation analysis was evaluated by weight loss. In this sense, the scaffold samples (1 cm2) previously dried in an oven (60 °C) for 24 h were submerged in 10 mL of PBS solution containing 1.5 µg/mL of lysozyme and maintained at 37 ± 0.5 °C. The PBS/Lysozyme solution was changed weekly to ensure enzyme activity. After the predetermined period (7, 14, 21 and 28 days), the samples were removed from the solution, washed in distilled water, dried (60 °C) for 24 h and weighed. The weight loss was calculated with Equation (2):
W e i g h t   l o s s   % = W 0 W t W 0 × 100 ,
where W0 is the initial mass of the sample and Wt is the mass of the sample taken out of the solution in the specified period of time.

2.3.6. Scanning Electron Microscopy

Scanning electron microscopy (SEM) was used to assess the scaffold morphology. The equipment utilized was a Hitachi model TM-1000 (Chiyoda, Tokyo, Japan) scanning electron microscope. The ImageJ software was used to analyze the porosity and the average pore size from the images obtained.

2.3.7. Cytotoxicity Assay

The cytotoxic activity of the scaffolds was evaluated using the agar diffusion method according to ISO 10993-5 (2009) [34].
Initially, the L929 Mouse Fibroblast Cell Lines (ATCC NCTC clone 929, Rio de Janeiro Cell Bank, Brazil) were cultured in RPMI 1640 medium (Gibco–Invitrogen Corporation, Grand Island, USA) containing 10% fetal bovine serum (BS–Gibco, Life Technologies) and 1% antibiotic-antimycotic (Gibco, Life Technologies) in culture dishes until they reach confluence. Then, the cells were trypsinized to be subcultured in a suspension with a concentration of 1.0 × 105 viable cells per mL, with the aid of an automatic cell counter (Invitrogen–Thermo Fisher, Waltham, MA, USA). The cell suspensions were distributed in 6 well plates (4 mL/well) and incubated for 48 h. After the establishment of cell cultures, the microplate culture medium was aspirated, and 1 mL of the cover medium (1.8% agar, 0.01% neutral red dye added and 2× concentrated MEM) was added in each well. The plates remained in the laminar flow hood for 10 min, protected from light, waiting for the agar to solidify at room temperature. The samples and controls were placed in contact with the solidified surface of the agar, in the center of each plate, in triplicate cultures. Thus, the plates were incubated and protected with aluminium foil to avoid cellular damage by the photoactivation of neutral red (ISO 10993-5) for at least 24 h in an oven at 37 °C, humidified with 5 ± 1% CO2 for cytotoxicity assessment. The presence of discoloration zones and cell lysis was evaluated using a NIKON ECLIPSE TS100 (Minato, Tokyo, Japan) inverted digital microscope.

2.3.8. Statistical Analysis

The statistical analysis of the data was performed by One-Way Analysis of Variance (ANOVA) and Tukey tests for the differences in means. The confidence level adopted will be 95%, and the significance level (α) was 0.005. For p-values greater than α, the difference between the means will be considered statistically insignificant. On the other hand, for p-values less than or equal to α, the difference between the means will be considered statistically significant.

3. Results and Discussion

3.1. High Performance Liquid Chromatography coupled to Diode Array Detector

The development process of the Jatropha mollissima ethanolic extract was successfully carried out. A yield of approximately 115 g of EEJM powder (Figure 1a) was achieved for 1 L of latex. In this sense, the HPLC-DAD technique was applied in the evaluation of the EEJM (Figure 1b).
According to Figure 1b, the separation of six significant substances can be observed. These substances were identified at a wavelength of 280 nm, which is characteristic of tannins [35], ellagitannins, phenolic compounds [36], iridoids [37], flavonoids, flavones and flavonols [38], among others. Plants of the genus Jatropha are known to have various classes of secondary metabolites in their composition [39]. Studies have indicated the presence of flavonoids, alkaloids, coumarins and lignins in J. gossypiifolia and J. curcas [39,40]. Other studies have shown the presence of flavonoids, polyphenols, saponins and condensed tannins in the extract of J. curcas leaves [41], and flavonoids and polyphenols in the ethyl acetate fraction of leaves and roots of J. macranta [42]. Other authors have also reported similar results [43,44,45,46], indicating that they align with the results found here.

3.2. Total Concentration of Phenols, Flavonoids and Condensed Tannins

The concentration of secondary metabolite classes is directly linked to the biological activity of the plant derivatives. The higher the concentration of metabolites, the greater the biological activity of the extracts. For this reason, quantifying the main classes of compounds present in plant extracts is necessary. In Table 2 are the total concentrations of polyphenols, flavonoids and condensed tannins that were quantified in the EEJM.
The results in Table 2 show that three classes of compounds, polyphenols, flavonoids and condensed tannins are present in the EEJM. The condensed tannins had the highest concentration, followed by the polyphenols and flavonoids. In the literature, research has been conducted to determine the concentration of secondary metabolites in plants of the genus Jatropha. Concentrations of phenols in the range of 400 to 150 μg·mL−1, flavonoids of 6 to 2 μg·mL−1 and tannins of 35 to 10 μg·mL−1 were identified in the aqueous, ethanolic, methanolic and ketone extracts of the seeds, roots, leaves, flowers and bark of J. curcas [41]. In studies by Fröhlich et al. [47], the total concentration of phenols, flavonoids and tannins in the crude extract and the dichloromethane, acetate and butanolic fractions of the roots of J. isabellei was determined. In their results, the acetate fraction showed the highest concentrations, with 685 μg·mg−1 for phenols, 25.90 μg·mg−1 for flavonoids and 15.63 μg·mg−1 for tannins. Tinco-Jayo et al. [42] estimated the concentration of phenolics in the range of 359 and 306 mg·g-1 and flavonoids in the range of 101–23.7 mg·g−1 in the ethyl acetate fraction of J. macrantha leaves.
Only a few studies have reported on the quantification of secondary metabolites in J. mollissima. In addition, there are still no studies that have determined the concentration of flavonoids and condensed tannins in the latex of J. mollissima. The existing studies focus on determining the concentration of phenols and flavonoids in its leaves and latex. For phenols, values of 245 μg·mg−1 in J. mollissima leaf extract [26] and 58.07 mg·g−1 in its latex [27] are reported; these results differ from the results from the concentrations obtained here. Such differences can be explained by the difference in the parts of the plant used to prepare the extracts (leaves, flowers, bark, roots and latex) [48,49] and due to the vegetative cycle, botanical origin and climatic factors [50]. Therefore, the results confirmed the presence of the class of phenols, flavonoids and tannins metabolites in the EEJM, highlighting the tannins which presented a concentration of 431.68 mg·g-1 and may be one of the main groups of compounds responsible for the biological activities of J. mollissima latex.

3.3. Fourier Transform Infrared Spectroscopy

The FTIR analyses for the scaffolds and precursor materials are shown in Figure 2. The obtained spectra present characteristic absorption bands for organic compounds.
In the chitosan spectrum, the band around 3335 cm−1 is associated with the stretching vibration of the OH and NH bonds. The peaks at 2900 and 1316 cm−1 are attributed to the symmetric and asymmetric stretching vibrations of the CH groups. The peaks at 1650 and 1570 cm−1 are characteristic amide I and II bands. The peaks at 1370 cm−1 and 1258 cm−1 are associated with the C-OH groups’ vibration and C-O bond stretching, respectively. The bands at 1150, 1074 and 1030 cm−1 are attributed to the C-O-C bond of the glycosidic bonds [51,52,53,54].
In the gelatin spectrum, the band at 3290 cm−1 corresponds to the stretching vibration of the hydroxyl groups (OH); the band at 2932 cm−1 is attributed to the CH2 asymmetric stretching vibration; the band at 1628 cm-1 is attributed to the (C=O) stretching vibration; the band at 1530 cm−1 is attributed to the N-H bending vibration; and the band at 1444 cm−1 is attributed to the symmetrical stretching of the -COOH groups, confirming the protein molecule [51,54,55].
The EEJM Spectrum shows a broad band at 3252 cm−1, which is related to the stretching of the binding of the hydroxyl groups of polyphenol compounds present in the extract [56,57,58]. Superimposed on this one, the band at 2972 cm−1 refers to the stretching vibrations CH, CH2 and CH3 of the alkanes and alkyl groups derived from carbohydrates and sugars [59,60]. The bands located at 1604, 1522 and 1438 cm−1 are attributed to the elongation of the C=C-C aromatic bonds [61]. The band with a peak at 1370 cm−1 refers to the stretching of the C-O bond and may also be associated with the bending vibrations of the OH bonds [62]. In consonance, the bands 1106 and 1058 cm−1 are related to the axial deformation of the C-O bonds, which is typical of esters, alcohols, ethers and carboxylic acids. Finally, the bands 820–772 cm−1 are attributed to the CH bond deformation vibrations [63]. There is no absorbance between the region 2220–2260 cm−1, indicating that there is no presence of cyanide groups (-C≡N) in the extract [64]. All of the compounds observed from the EEJM FTIR analysis belong to secondary metabolites and corroborate the evidence found by chromatography.
The scaffold spectra show a good mixture of the components in all of the developed compositions as the characteristic bands of chitosan, gelatin and EEJM can be observed. The chitosan/gelatin interaction might be a result of the partial conversion of the electrostatic bonds into chemical by hydrogen bonding, resulting from the interaction of the protonated amine of the chitosan and the carboxyl groups of the gelatin [54].

3.4. Swelling Degree

Swelling is a fundamental property for scaffolds in tissue engineering as it influences cell migration and the diffusion of nutrients on the scaffold [65]. Skin scaffolds should absorb wound exudates and keep the wound moist, promoting a faster and more effective healing process [66,67,68]. Concerning the development of dressings for the treatment of wounds, an inadequate SD can result in the accumulation of exudate, which, although essential for healing, can cause maceration of healthy tissues, resulting in a chronic wound [69,70]. Such observations justify the importance of crosslinking chitosan-based materials in modulating properties for wound healing applications. In Figure 3, the swelling scaffolds degree can be seen.
Considerably high SD values were reached (Figure 3), and a profile of a decrease in the property could also be observed with the increase in EEJM content in the scaffold, reaching, for CGE10, an average SD of 1620.89 ± 79.01. However, according to the Tukey’s test, the means of the SD do not differ statistically (p-value = 0.168). Once the samples have been neutralized, the high SD value can be associated with the porous structure and gelatin content due to the hydrophilic character of such biopolymer [71]. The authors of other studies report even higher values than those found here for chitosan/gelatin scaffolds [72]. This suggests that crosslinking with genipin occurred as it induces the formation of more crosslinks in the scaffolds, in turn decreasing the SD [73]. As for the decrease in the property with the increase in the EEJM content, this may be associated with the fact that the solution becomes more concentrated or that the addition of the extract has promoted a slightly less hydrophilic character to the composition.

3.5. Enzymatic Biodegradation

Enzymatic degradation perfectly simulates in vivo and clinical situations [74]. Lysozyme, an enzyme present in the body, promotes the enzymatic depolymerization of chitosan through the hydrolysis of the glycosidic bonds in its subunits, N-acetyl-glucosamine and glucosamine [75,76]. These amino-monosaccharides can be absorbed as they have chemical similarities with the components of the extracellular matrix (ECM) of soft tissues [77,78,79]. The absorption of glucosamine and its derivatives stimulate the synthesis of hyaluronic acid, collagen and other ECM glycosaminoglycans, in addition to promoting hydration and anti-inflammatory activity; these are properties that contribute to the success of the scaffold by supporting cell growth and proliferation in the engineering of the new tissue [80,81,82]. Gelatin, which is a product obtained from the thermal and chemical degradation of collagen, when placed in a physiological environment, undergoes enzymatic and hydrolysis degradation [83,84,85]. Its degradation products promote the proliferation of the cells associated with wound repair and skin regeneration, such as keratinocytes, in addition to being pro-angiogenic, which favors soft tissue repair [84,86,87].
The enzymatic biodegradation of the scaffolds (Figure 4) follows a pattern for the intervals of 7, 14, and 21 days, in which the increase in the extract content promotes a smaller weight loss, with the exception of the CGE10 sample, although this one still reaches lower values in 21 days to those obtained for CGE0 (sample without EEJM), of 32.61 ± 1.60 and 36.19 ± 6.49, respectively. After 28 days, the biodegradation profile is different, which is attributed to an increase in the breakdown of crosslinks, which makes the material (EEJM) more susceptible to degradation due to weight loss. Based on the Tukey’s test, the statistical significance of the addition of EEJM on the weight loss of the samples during the test period was confirmed (p-value = 0.037). It is noteworthy that in the evaluated period (28 days), the scaffolds showed a maximum mass loss of 42.89 ± 1.28% (CGE10), which can be attributed to crosslinking with genipin as the reported values of mass loss in the literature are superior to chitosan/gelatin scaffolds crosslinked with other agents [16,68].

3.6. Scanning Eelectron Microscopy (SEM)

Photographs (1) and SEM images (surface (2) and cross-section (3)) of the scaffolds are shown in Figure 5. As can be seen, the EEJM content affected the color of the scaffolds, leading to its characteristic reddish color (Figure 1a). All of the samples have an open pore structure with interconnected pores characteristic of the freeze-drying method [68,88,89]. An open pore structure is essential for cell attachment and blood supply [16].
Table 3 summarizes the average porosity (%) and pore size (μm) for all of the samples.
Porosity plays a crucial role in cell migration and proliferation as it influences gas and nutrient exchange, as well as swelling [90]. The scaffolds reached average porosity values, between 57 and 60%, close to those achieved in some other studies on chitosan/gelatin scaffolds [68,72,91]. As for pore size, an average pore size in the range of 100 and 200 µm is recommended in the literature for skin tissue engineering applications [89,92]. All of the developed scaffolds reached average pore size values in the described range, with the exception of CGE0 (227.67 ± 72.06). The increase in the EEJM content in the chitosan/gelatin scaffolds tends to decrease the mean pore size and make their formats more uniform as the standard deviations decrease (Table 3). In this sense, the potential of the extract to develop structures suitable for the requirements of skin tissue engineering is highlighted.
The average porosity values showed no statistical difference (p-value = 0.425). On the other hand, the average pore size was significantly affected by the incorporation of EEJM (p-value < 0.000), according to the grouping in Table 3.

3.7. Cytotoxicity

Chitosan/gelatin scaffolds are widely reported as noncytotoxic biomaterials [19,51,55]; however, there is no evidence of the combination of these with EEJM. As previously discussed, plant extracts such as EEJM have numerous bioactive secondary metabolites, and because of their complex structure, cytotoxicity investigations are essential. In this sense, the agar diffusion test was chosen to investigate the scaffold’s cytotoxicity. The method consists of evaluating the effects of the samples through an agar layer, which protects the cells from mechanical damage and allows the diffusion of substances from polymeric samples. Table 4 presents the results obtained from the agar diffusion test, while Figure 6 presents the complementary microscopies.
The negative control, HDPE, did not promote cell lysis (Figure 6a), while for the positive control, toxic latex, cell lysis was observed as a discoloration halo was formed (Figure 6b), reaching a cytotoxicity degree of 4 (severely cytotoxic) (Table 4). There is also no formation of discoloration halos for any of the compositions of the tested scaffolds (Figure 6c–h); thus, the samples did not promote cell lysis. The results confirm that chitosan/gelatin scaffolds loaded with EEJM up to 10% (w/w) are non-toxic to L929 cells, emphasizing their potential use as skin tissue engineering materials.

4. Conclusions

Porous chitosan/gelatin scaffolds crosslinked with genipin and loaded with different concentrations of Jatropha molissima extract were successfully obtained using the freeze-drying method. J. molissima latex showed a yield of 115 g/L of ethanolic extract, from which six main groups of secondary metabolites were identified; among these, the phenolic, flavonoid and tannin contents were quantified by chromatography. Spectroscopy showed good mixing and interaction between the precursor materials in the scaffolds. The scaffolds showed a high swelling capacity, above 1500%, which was not affected by the extract loading, such as its porosity. On the other hand, increasing the extract content slowed down the weight loss and reduced the average pore size of the samples. Furthermore, with the addition of the extract, the average pore size was compatible with the range reported for cell adhesion and proliferation. The scaffolds with and without the addition of the extract did not show cytotoxicity, which confirms the biocompatibility of the products obtained and their potential application in skin tissue engineering.

Author Contributions

Conceptualization, M.F.d.S. and R.C.B.; methodology, M.F.d.S., W.J.B.d.S. and R.C.B.; formal analysis, H.N.d.S., J.F.B.R. and R.C.B.; investigation, M.F.d.S. and M.D.M.M.; resources, M.V.L.F.; data curation, M.F.d.S., H.N.d.S., J.F.B.R.; writing—original draft preparation, M.F.d.S., H.N.d.S., J.F.B.R. and M.D.M.M.; writing—review and editing, M.F.d.S. and H.N.d.S.; supervision, W.J.B.d.S., R.C.B. and M.V.L.F.; funding acquisition, M.V.L.F. All authors have read and agreed to the published version of the manuscript. The CRediT (http://credit.niso.org/ accessed on 29 December 2022) was used to describe the contributions of each author.

Funding

This research received external funding from the Coordenação de Aperfeiçoamento dePessoal de Nível Superior (CAPES—Brazil), grant number 88887.602532/2021-00, and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq—Brazil), grant number 442745/2020-6.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors are grateful to the CAPES and CNPq, grant numbers 88887.602532/2021-00 and 442745/2020-6 respectively, for financial support; and to the Federal University of Campina Grande— UFCG (PB, Brazil) and Northeast Biomaterials Evaluation and Development Laboratory—CERTBIO for supporting the execution of this work. The authors are also grateful to Professor Simone Simões and to MSc. Tiago dos Santos Silva for providing the secondary metabolites determination analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Naghieh, S.; Sarker, M.; Izadifar, M.; Chen, X. Dispensing-based bioprinting of mechanically-functional hybrid scaffolds with vessel-like channels for tissue engineering applications-A brief review. J. Mech. Behav. Biomed. Mater. 2018, 78, 298–314. [Google Scholar] [CrossRef] [PubMed]
  2. Rahmani Del Bakhshayesh, A.; Annabi, N.; Khalilov, R.; Akbarzadeh, A.; Samiei, M.; Alizadeh, E.; Alizadeh-Ghodsi, M.; Davaran, S.; Montaseri, A. Recent advances on biomedical applications of scaffolds in wound healing and dermal tissue engineering. Artif. Cells Nanomed. Biotechnol. 2018, 46, 691–705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Rider, P.; Kacarevic, Z.P.; Alkildani, S.; Retnasingh, S.; Barbeck, M. Bioprinting of tissue engineering scaffolds. J. Tissue Eng. 2018, 9, 2041731418802090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Sikka, M.P.; Midha, V.K. 16-The role of biopolymers and biodegradable polymeric dressings in managing chronic wounds. In Advanced Textiles for Wound Care, 2nd ed.; Rajendran, S., Ed.; Woodhead Publishing: Sawston, UK, 2019; pp. 463–488. [Google Scholar]
  5. Cheng, Y.-H.; Hung, K.-H.; Tsai, T.-H.; Lee, C.-J.; Ku, R.-Y.; Chiu, A.W.-H.; Chiou, S.-H.; Liu, C.J.-L. Sustained delivery of latanoprost by thermosensitive chitosan–gelatin-based hydrogel for controlling ocular hypertension. Acta Biomater. 2014, 10, 4360–4366. [Google Scholar] [CrossRef]
  6. Ghaee, A.; Bagheri-Khoulenjani, S.; Amir Afshar, H.; Bogheiri, H. Biomimetic nanocomposite scaffolds based on surface modified PCL-nanofibers containing curcumin embedded in chitosan/gelatin for skin regeneration. Compos. Part B Eng. 2019, 177, 107339. [Google Scholar] [CrossRef]
  7. Rosellini, E.; Zhang, Y.S.; Migliori, B.; Barbani, N.; Lazzeri, L.; Shin, S.R.; Dokmeci, M.R.; Cascone, M.G. Protein/polysaccharide-based scaffolds mimicking native extracellular matrix for cardiac tissue engineering applications. J. Biomed. Mater. Res. Part A 2018, 106, 769–781. [Google Scholar] [CrossRef]
  8. Goy, R.C.; Britto, D.d.; Assis, O.B.G. A review of the antimicrobial activity of chitosan. Polímeros 2009, 19, 241–247. [Google Scholar] [CrossRef]
  9. Kim, S. Competitive Biological Activities of Chitosan and Its Derivatives: Antimicrobial, Antioxidant, Anticancer, and Anti-Inflammatory Activities. Int. J. Polym. Sci. 2018, 2018, 1708172. [Google Scholar] [CrossRef]
  10. Muxika, A.; Etxabide, A.; Uranga, J.; Guerrero, P.; de la Caba, K. Chitosan as a bioactive polymer: Processing, properties and applications. Int. J. Biol. Macromol. 2017, 105, 1358–1368. [Google Scholar] [CrossRef]
  11. Heimbuck, A.M.; Priddy-Arrington, T.R.; Padgett, M.L.; Llamas, C.B.; Barnett, H.H.; Bunnell, B.A.; Caldorera-Moore, M.E. Development of responsive chitosan–genipin hydrogels for the treatment of wounds. ACS Appl. Bio Mater. 2019, 2, 2879–2888. [Google Scholar] [CrossRef]
  12. Wahba, M.I. Enhancement of the mechanical properties of chitosan. J. Biomater. Sci. Polym. Ed. 2020, 31, 350–375. [Google Scholar] [CrossRef] [PubMed]
  13. Kildeeva, N.; Chalykh, A.; Belokon, M.; Petrova, T.; Matveev, V.; Svidchenko, E.; Surin, N.; Sazhnev, N. Influence of genipin crosslinking on the properties of chitosan-based films. Polymers 2020, 12, 1086. [Google Scholar] [CrossRef] [PubMed]
  14. Si, J.; Yang, Y.; Xing, X.; Yang, F.; Shan, P. Controlled degradable chitosan/collagen composite scaffolds for application in nerve tissue regeneration. Polym. Degrad. Stab. 2019, 166, 73–85. [Google Scholar] [CrossRef]
  15. Radhika Rajasree, S.R.; Gobalakrishnan, M.; Aranganathan, L.; Karthih, M.G. Fabrication and characterization of chitosan based collagen/gelatin composite scaffolds from big eye snapper Priacanthus hamrur skin for antimicrobial and anti oxidant applications. Mater. Sci. Eng. C 2020, 107, 110270. [Google Scholar] [CrossRef]
  16. Kumar, P.; Dehiya, B.S.; Sindhu, A. Comparative study of chitosan and chitosan–gelatin scaffold for tissue engineering. Int. Nano Lett. 2017, 7, 285–290. [Google Scholar] [CrossRef] [Green Version]
  17. Thein-Han, W.W.; Saikhun, J.; Pholpramoo, C.; Misra, R.D.K.; Kitiyanant, Y. Chitosan–gelatin scaffolds for tissue engineering: Physico-chemical properties and biological response of buffalo embryonic stem cells and transfectant of GFP–buffalo embryonic stem cells. Acta Biomater. 2009, 5, 3453–3466. [Google Scholar] [CrossRef]
  18. Huang, Y.; Onyeri, S.; Siewe, M.; Moshfeghian, A.; Madihally, S.V. In vitro characterization of chitosan–gelatin scaffolds for tissue engineering. Biomaterials 2005, 26, 7616–7627. [Google Scholar] [CrossRef]
  19. Xu, J.; Fang, H.; Zheng, S.; Li, L.; Jiao, Z.; Wang, H.; Nie, Y.; Liu, T.; Song, K. A biological functional hybrid scaffold based on decellularized extracellular matrix/gelatin/chitosan with high biocompatibility and antibacterial activity for skin tissue engineering. Int. J. Biol. Macromol. 2021, 187, 840–849. [Google Scholar] [CrossRef]
  20. Zhang, L.; Dong, Y.; Zhang, N.; Shi, J.; Zhang, X.; Qi, C.; Midgley, A.C.; Wang, S. Potentials of sandwich-like chitosan/polycaprolactone/gelatin scaffolds for guided tissue regeneration membrane. Mater. Sci. Eng. C 2020, 109, 110618. [Google Scholar] [CrossRef]
  21. Casimiro, M.H.; Ferreira, L.M.; Santos, P.M.P.; Leal, J.P.; Rodrigues, G.; Iria, I.; Alves, S.; Pais, D.; Casal, D. Chitosan-Based Membranes for Skin Wound Repair in a Dorsal Fold Chamber Rat Model. Pharmaceutics 2022, 14, 2736. [Google Scholar] [CrossRef]
  22. Kakaei, S.; Shahbazi, Y. Effect of chitosan-gelatin film incorporated with ethanolic red grape seed extract and Ziziphora clinopodioides essential oil on survival of Listeria monocytogenes and chemical, microbial and sensory properties of minced trout fillet. LWT-Food Sci. Technol. 2016, 72, 432–438. [Google Scholar] [CrossRef]
  23. Ahmadi, S.; Hivechi, A.; Bahrami, S.H.; Milan, P.B.; Ashraf, S.S. Cinnamon extract loaded electrospun chitosan/gelatin membrane with antibacterial activity. Int. J. Biol. Macromol. 2021, 173, 580–590. [Google Scholar] [CrossRef] [PubMed]
  24. Bertolo, M.R.V.; Martins, V.C.A.; Horn, M.M.; Brenelli, L.B.; Plepis, A.M.G. Rheological and antioxidant properties of chitosan/gelatin-based materials functionalized by pomegranate peel extract. Carbohydr. Polym. 2020, 228, 115386. [Google Scholar] [CrossRef] [PubMed]
  25. Sabandar, C.W.; Ahmat, N.; Jaafar, F.M.; Sahidin, I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): A review. Phytochemistry 2013, 85, 7–29. [Google Scholar] [CrossRef] [PubMed]
  26. Dias, W.L.F.; do Vale Junior, E.P.; das Dores Alves de Oliveira, M.; Barbosa, Y.L.P.; do Nascimento Silva, J.; da Costa Júnior, J.S.; de Almeida, P.M.; Martins, F.A. Cytogenotoxic effect, phytochemical screening and antioxidant potential of Jatropha mollissima (Pohl) Baill leaves. S. Afr. J. Bot. 2019, 123, 30–35. [Google Scholar] [CrossRef]
  27. Queiroz Neto, R.F.d.; Araújo Júnior, H.N.d.; Freitas, C.I.A.; Costa, K.M.d.F.M.; Abrantes, M.R.; Almeida, J.G.L.d.; Torres, T.M.; Moura, G.H.F.; Batista, J.S. The Jatropha mollissima (Pohl) Baill: Chemical and pharmacological activities of the latex and its extracts. Semin. Ciências Agrárias 2019, 40, 2613–2624. [Google Scholar] [CrossRef] [Green Version]
  28. Ribeiro, A.R.C.; Andrade, F.D.d.; Medeiros, M.d.C.d.; Camboim, A.d.S.; Pereira Júnior, F.A.; Athayde, A.C.R.; Rodrigues, O.G.; Silva, W.W. Estudo da atividade anti-helmíntica do extrato etanólico de Jatropha mollissima (Pohl) Baill.(Euphorbiaceae) sob Haemonchus contortus em ovinos no semiárido paraibano. Pesqui. Veterinária Bras. 2014, 34, 1051–1055. [Google Scholar] [CrossRef] [Green Version]
  29. Dantas, M.V.O.; Nogueira, P.L.; Lima, F.O.; Oliveira, D.C.P.; Gomes, E.N.S.; Rodrigues, J.F.B.; Amoah, S.K.S.; Rosendo, R.A.; da Penha, E.S.; Dantas, A.F.M.; et al. In vivo Hemostatic Activity of Jatropha mollissima: A Triple-Blinded, Randomized, Controlled Trial in an Animal Model. Eur. J. Dent. 2021, 15, 741–745. [Google Scholar] [CrossRef]
  30. Patel, B.; Wene, D.; Fan, Z.T. Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC/DAD method. J. Pharm. Biomed. Anal. 2017, 146, 15–23. [Google Scholar] [CrossRef]
  31. Aryal, S.; Baniya, M.K.; Danekhu, K.; Kunwar, P.; Gurung, R.; Koirala, N. Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from Western Nepal. Plants 2019, 8, 96. [Google Scholar] [CrossRef]
  32. Guleria, K.; Sehgal, A.; Bhat, I.A.; Singh, S.K.; Vamanu, E.; Singh, M.P. Impact of Altering the Ratio of Black Tea Granules and Ocimum gratissimum Leaves in a Binary Infusion on Radical Scavenging Potential Employing Cell Free Models and Ex Vivo Assays. Appl. Sci. 2022, 12, 10632. [Google Scholar] [CrossRef]
  33. Palacios, C.E.; Nagai, A.; Torres, P.; Rodrigues, J.A.; Salatino, A. Contents of tannins of cultivars of sorghum cultivated in Brazil, as determined by four quantification methods. Food Chem. 2021, 337, 127970. [Google Scholar] [CrossRef] [PubMed]
  34. ISO 10993-5; Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity. International Organization for Standardization: Geneve, Switzerland, 2009.
  35. Romani, A.; Campo, M.; Pinelli, P. HPLC/DAD/ESI-MS analyses and anti-radical activity of hydrolyzable tannins from different vegetal species. Food Chem. 2012, 130, 214–221. [Google Scholar] [CrossRef]
  36. Xiong, Y.; Zhang, P.; Warner, R.D.; Shen, S.; Johnson, S.; Fang, Z. Comprehensive profiling of phenolic compounds by HPLC-DAD-ESI-QTOF-MS/MS to reveal their location and form of presence in different sorghum grain genotypes. Food Res. Int. 2020, 137, 109671. [Google Scholar] [CrossRef] [PubMed]
  37. Karioti, A.; Giocaliere, E.; Guccione, C.; Pieraccini, G.; Gallo, E.; Vannacci, A.; Bilia, A.R. Combined HPLC-DAD–MS, HPLC–MSn and NMR spectroscopy for quality control of plant extracts: The case of a commercial blend sold as dietary supplement. J. Pharm. Biomed. Anal. 2014, 88, 7–15. [Google Scholar] [CrossRef] [PubMed]
  38. Manjón, E.; Recio-Torrado, A.; Ramos-Pineda, A.M.; García-Estévez, I.; Escribano-Bailón, M.T. Effect of different yeast mannoproteins on the interaction between wine flavanols and salivary proteins. Food Res. Int. 2021, 143, 110279. [Google Scholar] [CrossRef]
  39. Cavalcante, N.B.; da Conceição Santos, A.D.; da Silva Almeida, J.R.G. The genus Jatropha (Euphorbiaceae): A review on secondary chemical metabolites and biological aspects. Chem. Biol. Interact. 2020, 318, 108976. [Google Scholar] [CrossRef] [PubMed]
  40. Granados, S.; Balcázar, N.; Guillén, A.; Echeverri, F. Evaluation of the Hypoglycemic Effects of Flavonoids and Extracts from Jatropha gossypifolia L. Molecules 2015, 20, 6181–6193. [Google Scholar] [CrossRef] [Green Version]
  41. Rahu, M.I.; Naqvi, S.H.A.; Memon, N.H.; Idrees, M.; Kandhro, F.; Pathan, N.L.; Sarker, M.N.I.; Bhutto, M.A. Determination of antimicrobial and phytochemical compounds of Jatropha curcas plant. Saudi J. Biol. Sci. 2021, 28, 2867–2876. [Google Scholar] [CrossRef]
  42. Tinco-Jayo, J.A.; Aguilar-Felices, E.J.; Enciso-Roca, E.C.; Arroyo-Acevedo, J.L.; Herrera-Calderon, O. Phytochemical Screening by LC-ESI-MS/MS and Effect of the Ethyl Acetate Fraction from Leaves and Stems of Jatropha macrantha Müll Arg. on Ketamine-Induced Erectile Dysfunction in Rats. Molecules 2021, 27, 115. [Google Scholar] [CrossRef]
  43. Braquehais, I.D.; Vasconcelos, F.R.; Ribeiro, A.R.C.; Da Silva, A.R.A.; Franca, M.G.A.; De Lima, D.R.; De Paiva, C.F.; Guedes, M.I.F.; Magalhães, F.E.A. Estudo preliminar toxicológico, antibacteriano e fitoquímico do extrato etanólico das folhas de Jatropha mollissima (Pohl) Baill.(pinhão-bravo, Euphorbiaceae), coletada no Município de Tauá, Ceará, Nordeste Brasileiro. Rev. Bras. Plantas Med. 2016, 18, 582–587. [Google Scholar] [CrossRef] [Green Version]
  44. De Sousa Araújo, T.A.; Alencar, N.L.; de Amorim, E.L.C.; de Albuquerque, U.P. A new approach to study medicinal plants with tannins and flavonoids contents from the local knowledge. J. Ethnopharmacol. 2008, 120, 72–80. [Google Scholar] [CrossRef] [PubMed]
  45. Gomes, J.A.d.S.; Félix-Silva, J.; Morais Fernandes, J.; Geraldo Amaral, J.; Lopes, N.P.; Tabosa do Egito, E.S.; da Silva-Júnior, A.A.; Maria Zucolotto, S.; Fernandes-Pedrosa, M.d.F. Aqueous leaf extract of Jatropha mollissima (Pohl) bail decreases local effects induced by Bothropic venom. BioMed Res. Int. 2016, 2016, 6101742. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Iqbal, M.O.; Yahya, E.B. In vivo assessment of reversing aminoglycoside antibiotics nephrotoxicity using Jatropha mollissima crude extract. Tissue Cell 2021, 72, 101525. [Google Scholar] [CrossRef] [PubMed]
  47. Fröhlich, J.K.; Froeder, A.L.F.; Janovik, V.; Venturini, T.P.; Pereira, R.P.; Boligon, A.A.; de Brum, T.F.; Alves, S.H.; da Rocha, J.B.T.; Athayde, M.L. Antioxidant capacity, antimicrobial activity and triterpenes isolated from Jatropha isabellei Müll Arg. Nat. Prod. Res. 2013, 27, 1049–1059. [Google Scholar] [CrossRef]
  48. De la Rosa, L.A.; Moreno-Escamilla, J.O.; Rodrigo-García, J.; Alvarez-Parrilla, E. Phenolic compounds. In Postharvest Physiology and Biochemistry of Fruits and Vegetables; Elsevier: Amsterdam, The Netherlands, 2019; pp. 253–271. [Google Scholar]
  49. Wisetkomolmat, J.; Suppakittpaisarn, P.; Sommano, S.R. Detergent plants of Northern Thailand: Potential sources of natural saponins. Resources 2019, 8, 10. [Google Scholar] [CrossRef] [Green Version]
  50. De Araújo, L.G.; Veras, G.; de Oliveira Alves, J.V.; Oliveira de Veras, B.; da Silva, M.V.; Bacalhau Rodrigues, J.F.; Lia Fook, M.V.; Sagoe Amoah, S.K.; da Conceicao de Menezes Torres, M. Chemodiversity and Antibacterial Activity of the Essential Oil of Leaves of Croton argyrophyllus. Chem. Biodivers. 2020, 17, e2000575. [Google Scholar] [CrossRef]
  51. Badhe, R.V.; Bijukumar, D.; Chejara, D.R.; Mabrouk, M.; Choonara, Y.E.; Kumar, P.; du Toit, L.C.; Kondiah, P.P.D.; Pillay, V. A composite chitosan-gelatin bi-layered, biomimetic macroporous scaffold for blood vessel tissue engineering. Carbohydr. Polym. 2017, 157, 1215–1225. [Google Scholar] [CrossRef]
  52. Georgopoulou, A.; Papadogiannis, F.; Batsali, A.; Marakis, J.; Alpantaki, K.; Eliopoulos, A.G.; Pontikoglou, C.; Chatzinikolaidou, M. Chitosan/gelatin scaffolds support bone regeneration. J. Mater. Sci. Mater. Med. 2018, 29, 1–13. [Google Scholar] [CrossRef]
  53. Sarem, M.; Moztarzadeh, F.; Mozafari, M. How can genipin assist gelatin/carbohydrate chitosan scaffolds to act as replacements of load-bearing soft tissues? Carbohydr. Polym. 2013, 93, 635–643. [Google Scholar] [CrossRef]
  54. Peng, J.; Wang, X.; Lou, T. Preparation of chitosan/gelatin composite foam with ternary solvents of dioxane/acetic acid/water and its water absorption capacity. Polym. Bull. 2020, 77, 5227–5244. [Google Scholar] [CrossRef]
  55. Mohonta, S.K.; Maria, K.H.; Rahman, S.; Das, H.; Hoque, S.M. Synthesis of hydroxyapatite nanoparticle and role of its size in hydroxyapatite/chitosan–gelatin biocomposite for bone grafting. Int. Nano Lett. 2021, 11, 381–393. [Google Scholar] [CrossRef]
  56. Ajuong, E.; Birkinshaw, C. The effects of acetylation on the extractives of Sitka Spruce (Picea sitchensis) and Larch (Larix leptoleptis) wood. Holz Als Roh-Und Werkst. 2004, 62, 189–196. [Google Scholar] [CrossRef]
  57. Ping, L.; Pizzi, A.; Guo, Z.D.; Brosse, N. Condensed tannins from grape pomace: Characterization by FTIR and MALDI TOF and production of environment friendly wood adhesive. Ind. Crops Prod. 2012, 40, 13–20. [Google Scholar] [CrossRef]
  58. Rajan, T.; Muthukrishnana, S. Characterization of phenolic compounds in Pseudarthria viscida root extract by HPLC and FT-IR analysis. Asian J. Pharm. Clin. Res. 2013, 6, 274–276. [Google Scholar]
  59. Dos Santos Grasel, F.; Ferrão, M.F.; Wolf, C.R. Development of methodology for identification the nature of the polyphenolic extracts by FTIR associated with multivariate analysis. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2016, 153, 94–101. [Google Scholar] [CrossRef] [PubMed]
  60. Puică, N.M.; Pui, A.; Florescu, M. FTIR spectroscopy for the analysis of vegetable tanned ancient leather. Eur. J. Sci. Theol. 2006, 2, 49–53. [Google Scholar]
  61. Ahmad, T.; Ismail, A.; Ahmad, S.A.; Khalil, K.A.; Kumar, Y.; Adeyemi, K.D.; Sazili, A.Q. Recent advances on the role of process variables affecting gelatin yield and characteristics with special reference to enzymatic extraction: A review. Food Hydrocoll. 2017, 63, 85–96. [Google Scholar] [CrossRef]
  62. Cowen, S.; Al-Abadleh, H.A. DRIFTS studies on the photodegradation of tannic acid as a model for HULIS in atmospheric aerosols. Phys. Chem. Chem. Phys. 2009, 11, 7838–7847. [Google Scholar] [CrossRef]
  63. Ricci, A.; Olejar, K.J.; Parpinello, G.P.; Kilmartin, P.A.; Versari, A. Application of Fourier transform infrared (FTIR) spectroscopy in the characterization of tannins. Appl. Spectrosc. Rev. 2015, 50, 407–442. [Google Scholar] [CrossRef]
  64. Ragavendran, P.; Sophia, D.; Arul Raj, C.; Gopalakrishnan, V.K. Functional group analysis of various extracts of Aerva lanata (L.) by FTIR spectrum. Pharmacologyonline 2011, 1, 358–364. [Google Scholar]
  65. Sarika, P.R.; Cinthya, K.; Jayakrishnan, A.; Anilkumar, P.R.; James, N.R. Modified gum arabic cross-linked gelatin scaffold for biomedical applications. Mater. Sci. Eng. C 2014, 43, 272–279. [Google Scholar] [CrossRef] [PubMed]
  66. Sakthiguru, N.; Sithique, M.A. Fabrication of bioinspired chitosan/gelatin/allantoin biocomposite film for wound dressing application. Int. J. Biol. Macromol. 2020, 152, 873–883. [Google Scholar] [CrossRef] [PubMed]
  67. Hu, S.; Bi, S.; Yan, D.; Zhou, Z.; Sun, G.; Cheng, X.; Chen, X. Preparation of composite hydroxybutyl chitosan sponge and its role in promoting wound healing. Carbohydr. Polym. 2018, 184, 154–163. [Google Scholar] [CrossRef] [PubMed]
  68. Nokoorani, Y.D.; Shamloo, A.; Bahadoran, M.; Moravvej, H. Fabrication and characterization of scaffolds containing different amounts of allantoin for skin tissue engineering. Sci. Rep. 2021, 11, 1–20. [Google Scholar] [CrossRef]
  69. Ibrahim, N.I.; Wong, S.K.; Mohamed, I.N.; Mohamed, N.; Chin, K.-Y.; Ima-Nirwana, S.; Shuid, A.N. Wound healing properties of selected natural products. Int. J. Environ. Res. Public Health 2018, 15, 2360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Matica, M.A.; Aachmann, F.L.; Tøndervik, A.; Sletta, H.; Ostafe, V. Chitosan as a wound dressing starting material: Antimicrobial properties and mode of action. Int. J. Mol. Sci. 2019, 20, 5889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Afewerki, S.; Sheikhi, A.; Kannan, S.; Ahadian, S.; Khademhosseini, A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics. Bioeng. Transl. Med. 2019, 4, 96–115. [Google Scholar] [CrossRef]
  72. Carvalho, I.C.; Mansur, H.S. Engineered 3D-scaffolds of photocrosslinked chitosan-gelatin hydrogel hybrids for chronic wound dressings and regeneration. Mater. Sci. Eng. C 2017, 78, 690–705. [Google Scholar] [CrossRef]
  73. Yao, C.-H.; Chen, K.-Y.; Cheng, M.-H.; Chen, Y.-S.; Huang, C.-H. Effect of genipin crosslinked chitosan scaffolds containing SDF-1 on wound healing in a rat model. Mater. Sci. Eng. C 2020, 109, 110368. [Google Scholar] [CrossRef] [PubMed]
  74. Kilic Bektas, C.; Hasirci, V. Mimicking corneal stroma using keratocyte-loaded photopolymerizable methacrylated gelatin hydrogels. J. Tissue Eng. Regen. Med. 2018, 12, e1899–e1910. [Google Scholar] [CrossRef]
  75. Tanuma, H.; Saito, T.; Nishikawa, K.; Dong, T.; Yazawa, K.; Inoue, Y. Preparation and characterization of PEG-cross-linked chitosan hydrogel films with controllable swelling and enzymatic degradation behavior. Carbohydr. Polym. 2010, 80, 260–265. [Google Scholar] [CrossRef]
  76. Nordtveit, R.J.; Vårum, K.M.; Smidsrød, O. Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohydr. Polym. 1994, 23, 253–260. [Google Scholar] [CrossRef]
  77. Pan, S.-k.; Wu, S.-j.; Kim, J.-m. Preparation of glucosamine by hydrolysis of chitosan with commercial α-amylase and glucoamylase. J. Zhejiang Univ. Sci. B 2011, 12, 931. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Liu, L.; Liu, Y.; Shin, H.-d.; Chen, R.; Li, J.; Du, G.; Chen, J. Microbial production of glucosamine and N-acetylglucosamine: Advances and perspectives. Appl. Microbiol. Biotechnol. 2013, 97, 6149–6158. [Google Scholar] [CrossRef] [PubMed]
  79. Papakonstantinou, E.; Roth, M.; Karakiulakis, G. Hyaluronic acid: A key molecule in skin aging. Dermato-Endocrinology 2012, 4, 253–258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. Chen, R.-H.; Hsu, C.-N.; Chung, M.-Y.; Tsai, W.-L.; Liu, C.-H.J.J.o.F.; Analysis, D. Effect of Different Concentrations of Collagen, Ceramides, N-acetyl glucosamine, or Their Mixture on Enhancing the Proliferation of Keratinocytes, Fibroblasts and the Secretion of Collagen and/or the Expression of mRNA of Type I Collagen. J. Food Drug Anal. 2008, 16, 66–74. [Google Scholar] [CrossRef]
  81. Sayo, T.; Sakai, S.; Inoue, S. Synergistic Effect of N-Acetylglucosamine and Retinoids on Hyaluronan Production in Human Keratinocytes. Skin Pharmacol. Physiol. 2004, 17, 77–83. [Google Scholar] [CrossRef]
  82. Ashkani-Esfahani, S.; Emami, Y.; Esmaeilzadeh, E.; Bagheri, F.; Namazi, M.J. Glucosamine enhances tissue regeneration in the process of wound healing in rats as animal model: A stereological study. J. Cytol. Histol. 2012, 3, 1000150. [Google Scholar] [CrossRef] [Green Version]
  83. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Protein-based nanocarriers as promising drug and gene delivery systems. J. Control. Release 2012, 161, 38–49. [Google Scholar] [CrossRef]
  84. Tondera, C.; Hauser, S.; Krüger-Genge, A.; Jung, F.; Neffe, A.T.; Lendlein, A.; Klopfleisch, R.; Steinbach, J.; Neuber, C.; Pietzsch, J.J.T. Gelatin-based hydrogel degradation and tissue interaction in vivo: Insights from multimodal preclinical imaging in immunocompetent nude mice. Theranostics 2016, 6, 2114. [Google Scholar] [CrossRef] [PubMed]
  85. Ullm, S.; Krüger, A.; Tondera, C.; Gebauer, T.P.; Neffe, A.T.; Lendlein, A.; Jung, F.; Pietzsch, J. Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties. Biomaterials 2014, 35, 9755–9766. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Brandao-Rangel, M.A.; Oliveira, C.R.; da Silva Olímpio, F.R.; Aimbire, F.; Mateus-Silva, J.R.; Chaluppe, F.A.; Vieira, R.P. Hydrolyzed Collagen Induces an Anti-Inflammatory Response That Induces Proliferation of Skin Fibroblast and Keratinocytes. Nutrients 2022, 14, 4975. [Google Scholar] [CrossRef] [PubMed]
  87. Dreesmann, L.; Ahlers, M.; Schlosshauer, B. The pro-angiogenic characteristics of a cross-linked gelatin matrix. Biomaterials 2007, 28, 5536–5543. [Google Scholar] [CrossRef] [PubMed]
  88. Karimi, Z.; Ghorbani, M.; Hashemibeni, B.; Bahramian, H. Evaluation of the proliferation and viability rates of nucleus pulposus cells of human intervertebral disk in fabricated chitosan-gelatin scaffolds by freeze drying and freeze gelation methods. Adv. Biomed. Res. 2015, 4, 251. [Google Scholar]
  89. Han, F.; Dong, Y.; Su, Z.; Yin, R.; Song, A.; Li, S. Preparation, characteristics and assessment of a novel gelatin–chitosan sponge scaffold as skin tissue engineering material. Int. J. Pharm. 2014, 476, 124–133. [Google Scholar] [CrossRef] [PubMed]
  90. Annabi, N.; Nichol, J.W.; Zhong, X.; Ji, C.; Koshy, S.; Khademhosseini, A.; Dehghani, F.J. Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng. Part B Rev. 2010, 16, 371–383. [Google Scholar] [CrossRef] [Green Version]
  91. Shamloo, A.; Sarmadi, M.; Aghababaie, Z.; Vossoughi, M. Accelerated full-thickness wound healing via sustained bFGF delivery based on a PVA/chitosan/gelatin hydrogel incorporating PCL microspheres. Int. J. Pharm. 2018, 537, 278–289. [Google Scholar] [CrossRef] [PubMed]
  92. Jiankang, H.; Dichen, L.; Yaxiong, L.; Bo, Y.; Bingheng, L.; Qin, L. Fabrication and characterization of chitosan/gelatin porous scaffolds with predefined internal microstructures. Polymer 2007, 48, 4578–4588. [Google Scholar] [CrossRef]
Figure 1. (a) EEJM powder appearance and (b) EEJM fingerprint chromatogram in 280 nm for identification of secondary metabolites.
Figure 1. (a) EEJM powder appearance and (b) EEJM fingerprint chromatogram in 280 nm for identification of secondary metabolites.
Polymers 15 00603 g001
Figure 2. Scaffolds and precursor materials characteristic bands obtained by FTIR.
Figure 2. Scaffolds and precursor materials characteristic bands obtained by FTIR.
Polymers 15 00603 g002
Figure 3. Swelling degree of scaffolds (n = 3).
Figure 3. Swelling degree of scaffolds (n = 3).
Polymers 15 00603 g003
Figure 4. In Vitro enzymatic biodegradation of scaffolds at intervals of 7, 14, 21, and 28 days (n = 3).
Figure 4. In Vitro enzymatic biodegradation of scaffolds at intervals of 7, 14, 21, and 28 days (n = 3).
Polymers 15 00603 g004
Figure 5. Photographs (column 1) and SEM pictures of scaffolds surface (column 2) and cross section (column 3): CGE0 (a), CGE1 (b), CGE2.5 (c), CGE5 (d), CGE7.5 (e) and CGE10 (f).
Figure 5. Photographs (column 1) and SEM pictures of scaffolds surface (column 2) and cross section (column 3): CGE0 (a), CGE1 (b), CGE2.5 (c), CGE5 (d), CGE7.5 (e) and CGE10 (f).
Polymers 15 00603 g005
Figure 6. Agar diffusion test images: negative control (a), positive control (b), CGE0 (c), CGE1 (d), CGE2.5 (e), CGE5 (f), CGE7.5 (g) and CGE10 (h). All images were taken at the same magnification (100×). The shaded regions in the images are the scaffold samples.
Figure 6. Agar diffusion test images: negative control (a), positive control (b), CGE0 (c), CGE1 (d), CGE2.5 (e), CGE5 (f), CGE7.5 (g) and CGE10 (h). All images were taken at the same magnification (100×). The shaded regions in the images are the scaffold samples.
Polymers 15 00603 g006
Table 1. Codes for developed scaffolds and corresponding EEJM content.
Table 1. Codes for developed scaffolds and corresponding EEJM content.
Sample DesignationAmount of EEJM (%)
CGE00
CGE11
CGE2.52.5
CGE55
CGE7.57.5
CGE1010
C: chitosan; G: gelatin; E: EEJM.
Table 2. Total phenolic, flavonoid and condensed tannins content present in the J. mollissima ethanolic extract (n = 3).
Table 2. Total phenolic, flavonoid and condensed tannins content present in the J. mollissima ethanolic extract (n = 3).
SampleTPC (mg GAE/g Dry Extract)TFC (mg QE/g Dry Extract)TTC (mg CE/g Dry Extract)
EEJM22.91 ± 0.842.96 ± 0.45431.68 ± 33.43
TPC: total phenolic content; TFC: total flavonoid content; TTC: total tannin content.
Table 3. Porosity and average pore size values (mean ± standard deviation) for the developed scaffolds (n = 3). The letters “A”, “B”, “C” and “D” are the groupings provided by Tukey’s method, in which averages that do not share letters are significantly different.
Table 3. Porosity and average pore size values (mean ± standard deviation) for the developed scaffolds (n = 3). The letters “A”, “B”, “C” and “D” are the groupings provided by Tukey’s method, in which averages that do not share letters are significantly different.
Scaffold SamplePorosity (%)Mean Pore Size (µm)
CGE059.27 ± 0.96 (A)227.67 ± 72.06 (A)
CGE157.83 ± 1.73 (A)185.86 ± 55.08 (B)
CGE2.558.55 ± 0.78 (A)168.41 ± 57.74 (B, C)
CGE557.20 ± 1.29 (A)165.04 ± 48.22 (B, C, D)
CGE7.557.41 ± 1.38 (A)138.44 ± 34.22 (C, D)
CGE1057.29 ± 1.89 (A)155.20 ± 44.23 (D)
Table 4. Cytotoxicity classification of the samples by agar diffusion test.
Table 4. Cytotoxicity classification of the samples by agar diffusion test.
SampleCytotoxic DegreeDefinition
Negative control0Noncytotoxic
Positive control4Severely cytotoxic
CGE00Noncytotoxic
CGE10Noncytotoxic
CGE2.50Noncytotoxic
CGE50Noncytotoxic
CGE7.50Noncytotoxic
CGE100Noncytotoxic
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

de Souza, M.F.; da Silva, H.N.; Rodrigues, J.F.B.; Macêdo, M.D.M.; de Sousa, W.J.B.; Barbosa, R.C.; Fook, M.V.L. Chitosan/Gelatin Scaffolds Loaded with Jatropha mollissima Extract as Potential Skin Tissue Engineering Materials. Polymers 2023, 15, 603. https://doi.org/10.3390/polym15030603

AMA Style

de Souza MF, da Silva HN, Rodrigues JFB, Macêdo MDM, de Sousa WJB, Barbosa RC, Fook MVL. Chitosan/Gelatin Scaffolds Loaded with Jatropha mollissima Extract as Potential Skin Tissue Engineering Materials. Polymers. 2023; 15(3):603. https://doi.org/10.3390/polym15030603

Chicago/Turabian Style

de Souza, Matheus Ferreira, Henrique Nunes da Silva, José Filipe Bacalhau Rodrigues, Maria Dennise Medeiros Macêdo, Wladymyr Jefferson Bacalhau de Sousa, Rossemberg Cardoso Barbosa, and Marcus Vinícius Lia Fook. 2023. "Chitosan/Gelatin Scaffolds Loaded with Jatropha mollissima Extract as Potential Skin Tissue Engineering Materials" Polymers 15, no. 3: 603. https://doi.org/10.3390/polym15030603

APA Style

de Souza, M. F., da Silva, H. N., Rodrigues, J. F. B., Macêdo, M. D. M., de Sousa, W. J. B., Barbosa, R. C., & Fook, M. V. L. (2023). Chitosan/Gelatin Scaffolds Loaded with Jatropha mollissima Extract as Potential Skin Tissue Engineering Materials. Polymers, 15(3), 603. https://doi.org/10.3390/polym15030603

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop